Johnson & Johnson stock dips with sideways action likely in narrow range: weekly review

Traders Union
All News
Financial News
Johnson & Johnson falls 4.90% this week

Highlights

Johnson & Johnson stock displays moderate medium-term weakness but maintains a bullish long-term structure above key support levels.
Momentum indicators signal underlying bullishness despite a recent 4.9% weekly drop and short-term oversold readings.
JNJ is expected to consolidate between $231.77 and $233.59 next week, with a 75% probability of upward movement according to most technical signals.

Earnings beat and new recommendations boost confidence amid robust results

Johnson & Johnson reported quarterly earnings of $2.70 per share, exceeding consensus estimates and demonstrating strong financial performance with a net margin of 21.83% and return on equity of 32.60%. The company generated revenues of $24.06 billion for the period, signaling ongoing operational strength. Element Capital Management’s acquisition of a $2,564,000 stake highlighted institutional confidence, while NICE in England recommended Darzalex, broadening its therapeutic reach.

Short-term overselling as bullish momentum persists over the week

On the weekly (W1) timeframe, JNJ trades below its MA-20 but above both MA-50 and MA-200, suggesting short-term weakness set against a firm long-term trend. Weekly MACD and ADX still indicate bullish momentum, though the $11.77 drop puts the price at the lower end of its recent range. The RSI remains on buy, yet Stochastic RSI has moved to oversold territory and CCI is neutral, pointing to short-term overselling. The Awesome Oscillator confirms underlying upward momentum and the weekly Bull/Bear Power reads overbought, amid 5.83% volatility for the week.

Rangebound outlook as indicators favor upside after recent drop

Over the next 5 trading days, JNJ is forecast to consolidate in a narrow range between $231.77 and $233.59, with a 75% probability of an upward move suggested by RSI, ADX, and MACD. The baseline scenario is sideways action, stabilizing after last week’s decline. Should the price break above $233.59, renewed medium-term bullish momentum is likely, while a fall below $231.77 would indicate additional near-term selling pressure.

Anton Kharitonov, expert at Traders Union, notes that Johnson & Johnson ended the week with a pronounced decline of 4.9%, closing well below its weekly MA-20 but still holding the long-term uptrend above MA-50 and MA-200. He points out that despite strong quarterly earnings and positive institutional sentiment, the drop to the bottom of the weekly range reflects moderate selling pressure and short-term overselling. The technical setup shows bullish signals from MACD and ADX, but the Stochastic RSI warns that price weakness could persist into next week. Kharitonov sees the probability of a rebound at 75%, with a stabilizing sideways move expected between $231.77 and $233.59. Unless the price breaks above $233.59, he remains cautious about renewed upside. "The risk of further consolidation remains high this week, and I only trust the bullish momentum if we see a resolute move above $233.59."

Earlier, analysts noted that Johnson & Johnson maintained a bullish technical structure driven by strong momentum and positive corporate developments. The current period introduces increased short-term volatility and a test of immediate support levels, making a decisive move above $233.59 a key signal for potential renewed upside.

Source of Data: JNJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.